<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang Y</submitter><funding>Science and Technology Development in Henan Province</funding><funding>Foundation of Henan Educational Committee</funding><funding>National Natural Science Foundation of China</funding><pagination>37</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11948754</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(1)</volume><pubmed_abstract>Neuroblastoma is a pediatric embryonal malignancy characterized by impaired neuronal differentiation. Differentiation status in neuroblastoma strongly affects the clinical outcome, thus, enforcement of differentiation becomes a treatment strategy for this disease. However, the molecular mechanisms that control neuroblastoma differentiation are poorly understood. As an extensively studied protein of the activator protein-1 (AP-1) complex, c-Jun is involved in numerous cell regulations such as proliferation, survival and differentiation. In the current study, we demonstrated that c-Jun expression was upregulated by retinoic acid (RA) and flow cytometry assay indicated c-Jun overexpression arrested cell cycle to G1 phase, which, in turn, promoted the initiation of neuroblastoma cell different</pubmed_abstract><journal>Biology direct</journal><pubmed_title>c-Jun promotes neuroblastoma cell differentiation by inhibiting APC formation via CDC16 and reduces neuroblastoma malignancy.</pubmed_title><pmcid>PMC11948754</pmcid><funding_grant_id>32200804</funding_grant_id><funding_grant_id>242102311048</funding_grant_id><funding_grant_id>23A310016</funding_grant_id><pubmed_authors>Leng Q</pubmed_authors><pubmed_authors>Ji S</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Huang J</pubmed_authors><pubmed_authors>Guo H</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Song Z</pubmed_authors><pubmed_authors>Fang N</pubmed_authors></additional><is_claimable>false</is_claimable><name>c-Jun promotes neuroblastoma cell differentiation by inhibiting APC formation via CDC16 and reduces neuroblastoma malignancy.</name><description>Neuroblastoma is a pediatric embryonal malignancy characterized by impaired neuronal differentiation. Differentiation status in neuroblastoma strongly affects the clinical outcome, thus, enforcement of differentiation becomes a treatment strategy for this disease. However, the molecular mechanisms that control neuroblastoma differentiation are poorly understood. As an extensively studied protein of the activator protein-1 (AP-1) complex, c-Jun is involved in numerous cell regulations such as proliferation, survival and differentiation. In the current study, we demonstrated that c-Jun expression was upregulated by retinoic acid (RA) and flow cytometry assay indicated c-Jun overexpression arrested cell cycle to G1 phase, which, in turn, promoted the initiation of neuroblastoma cell different</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-06-01T14:43:10.89Z</modification><creation>2025-07-01T03:04:52.931Z</creation></dates><accession>S-EPMC11948754</accession><cross_references><pubmed>40149013</pubmed><doi>10.1186/s13062-025-00630-1</doi></cross_references></HashMap>